Symptomatic Relief after Grass Nasal Immunotherapy: Lasting Efficacy after 4-5 Years

Journal of Investigational Allergology and Clinical Immunology

Volumn 13, Issue 4, 2003, Pages 228-231

  Andri, L ^a   Falagiani, Paolo ^b  

^a MAGGIORE HOSPITAL   (Italy)

^b Lofarma SpA   (Italy)

Author keywords

Allergy; Clinical efficacy duration; Grass pollen; Local nasal immunotherapy (LNIT)

Indexed keywords

ALLERKIN; GRASS POLLEN EXTRACT;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; FOLLOW UP; GRASS POLLEN; HUMAN; IMMUNOTHERAPY; OPEN STUDY; POLLEN ALLERGY; RHINOCONJUNCTIVITIS; TREATMENT OUTCOME;

CONJUNCTIVITIS, ALLERGIC; HUMANS; IMMUNOTHERAPY; POACEAE; POLLEN; QUESTIONNAIRES; RHINITIS, ALLERGIC, SEASONAL; TIME FACTORS;

EID: 0742288507     PISSN: 10189068     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Grammer, L.C., Saughnessy, M.A., Suszko, I.M., Saughnessy, J.J., Patterson, R. Persistence of efficacy after a brief course of polymerized ragweed allergen: a controlled study. J Allergy Clin Immunol 1984; 73:484-489.
2. Mosbech, H., Østerballe, O. Does the effect of immunotherapy last after termination of the treatment? Allergy 1988; 43:523-529.
3. Hedlin, G., Heilborn, H., Lilija, G., Norrlind, K., Pegelow, K-O., Schou, C., Løwenstein, H. Long-term follow-up of patients treated with a three-year course of cat or dog immunotherapy. J Allergy Clin Immunol 1995; 96:879-885.
4. Des Roches, A., Paradis, L., Knani, J., Dhivert, H., Chanez, P., Bousquet, J. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. V. Duration of the efficacy of immunotherapy after its cessation. Allergy 1996; 51:430-433.
5. Jacobsen, L., Nüchel Petersen, B., Wihl, J.A., Løwenstein, H., Ipsen, H. Immunotherapy with partially purified and standardized tree pollen extracts. IV. Results from long-term (6-year) follow-up. Allergy 1997; 52:914-920.
6. Ariano, R., Kroon, A.M., Canonica, G.W., Passalacqua, G. Long-term treatment with allergoid immunotherapy with Parietaria. Clinical and immunologic effects in a randomized, controlled study. Allergy 1999; 54:313-319.
7. Cools, M., Van Bever, HP., Weyler, J.J., Stevens, W.J. Long-term effects of specific immunotherapy, administered during childhood, in asthmatic patients allergic to either house-dust mite or to both house-dust mite and grass pollen. Allergy 2000; 55:69-73.
8. Andri, L., Senna, G.E., Betteli, C., Givanni, S., Andri, G., Falagiani, P. Local nasal immunotherapy in allergic rhinitis to Parietaria. Allergy 1992; 47:318-323.
9. Andri, L., Senna, G.E., Betteli, C., Givanni, S., Andri, G., Falagiani, P. Local nasal immunotherapy for Dermatophagoides-induced rhinitis: Efficacy of a powder extract. J Allergy Clin Immunol 1993; 91:987-996.
10. Andri, L., Senna, G.E., Andri, G., Dama, A., Givanni, S., Betteli, C., Dimitri, G., Falagiani, P., Mezzelani, P. Local nasal immunotherapy for birch allergic rhinitis with extract in powder form. Clin Exp Allergy 1995; 25:1092-1099.
11. D'Amato, G., Lobefalo, G., Liccardi, G., Cazzola, M.A. A double blind placebo controlled trial of local nasal immunotherapy in allergic rhinitis to Parietaria pollen. Clin Exp Allergy 1995; 25:141-148.
12. Andri, L., Senna, G.E., Betteli, C., Givanni, S., Dimitri, G., Falagiani, P. Local nasal immunotherapy with extract in powder form is effective and safe in grass allergic rhinitis: A double blind study. J Allergy Clin Immunol 1996; 97:34-41.
13. Andri, L., Senna, G.E., Dama, A.R. Clinical efficacy and safety of local nasal immunotherapy. Review. Allergy 1997; 52(33 Suppl):36-39.
14. Cirla, A.M., Sforza, N., Roffi, G.P., Alessandrini, A., Stanizzi, R., Dorigo, N., Sala, E., Della Torre, F. Preseasonal intranasal immunotherapy in birch-alder allergic rhinitis. A double-blind study. Allergy 1996; 51:299-305.
15. Falagiani, P. Intranasal immunotherapy. Allergy 1999; 54(58 Suppl):53-55. Review.
16. Motta, G., Passali, D., De Vincentiis, I., Ottaviani, A., Maurizi, M., Sartoris, A., Pallestrini, E., Motta, S., Salzano, S.A. A multicenter trial of specific local nasal immunotherapy. Laryngoscope 2000; 110:132-139.
17. Bousquet, J., Lockey, R.F., Malling, H-J. (Editors). WHO Position Paper. Allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy 1998; 44(53 Suppl):1-42.
18. Passalacqua, G., Albano, M., Pronzato, C., Riccio, M., Scordamaglia, A., Falagiani, P., Canonica, G.W. Long-term follow-up of nasal immunotherapy to Parietaria: Clinical and immunological effects. Clin Exp Allergy 1997; 27:904-908.
19. Senna, G.E., Andri, G., Dama, A.R., Falagiani, P., Andri, L. Local nasal immunotherapy: efficacy and tolerability of two different administration schedules in grass pollen rhinitis. Allergol et Immunopathol 2000; 28:238-242.
20. Giannarini, L., Maggi, E. Decrease of allergen-specific T-cell response induced by local nasal immunotherapy. Clin Exp Allergy 1998; 28:404-414.
21. Pocobelli, D., Del Bono, A., Venuti, L., Falagiani, P., Venuti, A. Nasal immunotherapy at constant dosage: A double-blind, placebo-controlled study in grass-allergic rhinoconjunctivitis. J Invest Allergol Clin Immunol 2001; 11:79-88.
22. Van Neerven, R.J.J., Ebner, C., Yssel, H., Kapsenberg, M.L., Lamb, J.R. T-cell response to allergens: epitope-specificity and clinical relevance. Immunol Today 1996; 17:526-532.